<!DOCTYPE html>
<html lang="en">
<head>
<meta name="robots" content="noindex, nofollow">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Theoretical Framework — Judicialização da Saúde</title>
<style>
  :root {
    --bg: #f8f9fa; --card: #fff; --fg: #1a1a1a; --muted: #666;
    --border: #dee2e6; --accent: #0d6efd; --accent2: #198754;
  }
  * { box-sizing: border-box; margin: 0; padding: 0; }
  body {
    font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, sans-serif;
    background: var(--bg); color: var(--fg); line-height: 1.5;
  }

  main {
    padding: 1.5rem 2rem 3rem; max-width: 900px; margin: 0 auto;
  }

  /* Markdown body styles */
  .md-body { font-size: .92rem; line-height: 1.7; color: #1f2328; }

  .md-body h1 { font-size: 1.5rem; font-weight: 600; margin: 1.8rem 0 .8rem; padding-bottom: .3rem; border-bottom: 1px solid var(--border); }
  .md-body h2 { font-size: 1.25rem; font-weight: 600; margin: 1.6rem 0 .6rem; padding-bottom: .25rem; border-bottom: 1px solid var(--border); }
  .md-body h3 { font-size: 1.05rem; font-weight: 600; margin: 1.3rem 0 .5rem; }
  .md-body h4 { font-size: .95rem; font-weight: 600; margin: 1.1rem 0 .4rem; }
  .md-body h5, .md-body h6 { font-size: .88rem; font-weight: 600; margin: 1rem 0 .4rem; }
  .md-body h1:first-child { margin-top: 0; }

  .md-body p { margin: 0 0 .8rem; }

  .md-body ul, .md-body ol { margin: 0 0 .8rem; padding-left: 1.8rem; }
  .md-body li { margin-bottom: .25rem; }
  .md-body li > ul, .md-body li > ol { margin-top: .25rem; margin-bottom: 0; }

  /* Task lists */
  .md-body ul li { list-style: disc; }
  .md-body li input[type="checkbox"] {
    margin-right: .4rem; vertical-align: middle; position: relative; top: -1px;
  }

  .md-body a { color: var(--accent); text-decoration: none; }
  .md-body a:hover { text-decoration: underline; }

  .md-body strong { font-weight: 600; }

  .md-body blockquote {
    margin: 0 0 .8rem; padding: .4rem 1rem;
    border-left: 4px solid var(--accent); background: #f0f4f8;
    color: #555; font-size: .88rem;
  }
  .md-body blockquote p:last-child { margin-bottom: 0; }

  .md-body code {
    font-family: "SFMono-Regular", Consolas, "Liberation Mono", Menlo, monospace;
    font-size: .85em; background: #eef1f5; padding: .15rem .35rem;
    border-radius: 4px;
  }
  .md-body pre {
    margin: 0 0 .8rem; padding: .9rem 1rem;
    background: #f6f8fa; border: 1px solid var(--border);
    border-radius: 6px; overflow-x: auto; line-height: 1.45;
  }
  .md-body pre code {
    background: none; padding: 0; font-size: .82rem;
  }

  .md-body table {
    width: 100%; border-collapse: collapse; margin: 0 0 .8rem;
    font-size: .85rem; display: block; overflow-x: auto;
  }
  .md-body th, .md-body td {
    padding: .45rem .7rem; border: 1px solid var(--border); text-align: left;
  }
  .md-body th { background: #f0f4f8; font-weight: 600; }
  .md-body tr:nth-child(even) td { background: #fafbfc; }

  .md-body hr {
    border: none; border-top: 1px solid var(--border); margin: 1.5rem 0;
  }

  .md-body img { max-width: 100%; }

  /* Collapsible sections */
  .doc-controls { margin-bottom: 1rem; }
  .doc-controls button {
    font-size: .8rem; padding: .3rem .7rem; cursor: pointer;
    background: var(--card); border: 1px solid var(--border); border-radius: 4px;
    color: var(--accent); font-weight: 600;
  }
  .doc-controls button:hover { background: #e7f1ff; }
  .md-body details { margin-bottom: .5rem; }
  .md-body details summary {
    font-weight: 600; cursor: pointer; list-style: none;
  }
  .md-body details summary::-webkit-details-marker { display: none; }
  .md-body details summary::before {
    content: "\25b6"; font-size: .7em; margin-right: .5rem;
    display: inline-block; transition: transform .15s;
  }
  .md-body details[open] summary::before { transform: rotate(90deg); }
  .md-body details.level-2 > summary {
    font-size: 1.25rem; padding-bottom: .25rem;
    border-bottom: 1px solid var(--border); margin: 1.6rem 0 .6rem;
  }
  .md-body details.level-3 > summary {
    font-size: 1.05rem; margin: 1.3rem 0 .5rem;
  }

  footer {
    text-align: center; padding: 1.5rem; font-size: .8rem; color: var(--muted);
    border-top: 1px solid var(--border); margin-top: 2rem;
  }
</style>
</head>
<body>

<style>
  .site-nav {
    position: sticky; top: 0; z-index: 100;
    background: #212529; display: flex; align-items: center;
    padding: 0 2rem; height: 3rem;
  }
  .site-nav .nav-brand {
    color: #fff; text-decoration: none; font-weight: 600; font-size: 1rem;
    margin-right: auto;
  }
  .site-nav .nav-brand:hover { color: #e9ecef; }
  .site-nav .nav-link {
    color: #adb5bd; text-decoration: none; font-size: .85rem;
    padding: 0 .75rem; height: 3rem; display: flex; align-items: center;
    background: none; border: none; cursor: pointer; font-family: inherit;
  }
  .site-nav .nav-link:hover, .site-nav .nav-link.active { color: #fff; }
  .nav-dropdown { position: relative; }
  .dropdown-menu {
    display: none; position: absolute; top: 3rem; right: 0;
    background: #fff; border: 1px solid var(--border); border-radius: 6px;
    box-shadow: 0 4px 16px rgba(0,0,0,.12); min-width: 220px;
    padding: .4rem 0; z-index: 200; max-height: 80vh; overflow-y: auto;
  }
  .nav-dropdown.open .dropdown-menu { display: block; }
  .dropdown-menu a {
    display: block; padding: .3rem 1rem; color: #1a1a1a;
    text-decoration: none; font-size: .82rem;
  }
  .dropdown-menu a:hover { background: #f0f4f8; }
  .dropdown-group-label {
    padding: .4rem 1rem .15rem; font-size: .68rem; font-weight: 700;
    color: #888; text-transform: uppercase; letter-spacing: .04em;
  }
  .dropdown-divider { border-top: 1px solid #eee; margin: .3rem 0; }
  .page-header {
    padding: .8rem 2rem; border-bottom: 1px solid var(--border); background: #fff;
  }
  .page-header h1 { font-size: 1.3rem; font-weight: 600; }
  .page-header p { color: var(--muted); font-size: .85rem; margin-top: .15rem; }
</style>

<nav class="site-nav">
  <a href="../index.html" class="nav-brand">Judicialização da Saúde</a>
  <a href="../paper/index.html" class="nav-link">Paper</a>
  <div class="nav-dropdown">
    <button class="nav-link active">Docs &#9662;</button>
    <div class="dropdown-menu">
    <div class="dropdown-group-label">Research reference</div>
    <a href="../docs/README.html">Project Overview</a>
    <a href="../docs/summary.html">Research Summary</a>
    <a href="../docs/institutions.html">Institutional Background</a>
    <a href="../docs/data.html">Data Sources</a>
    <a href="../docs/methods.html">Empirical Methods</a>
    <a href="../docs/literature.html">Literature</a>
    <a href="../docs/theory.html">Theoretical Framework</a>
    <a href="../docs/hypotheses.html">Hypotheses & Evidence</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Working notes</div>
    <a href="../docs/thinking.html">Open Questions & Ideas</a>
    <a href="../docs/decisions.html">Key Decisions</a>
    <a href="../docs/qa.html">Research Q&A</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Task tracking</div>
    <a href="../docs/todo.html">Active Tasks</a>
    <a href="../docs/done.html">Completed Tasks</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Communication</div>
    <a href="../docs/meetings.html">Meeting Notes</a>
    <a href="../docs/feedback.html">External Feedback</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Court analysis</div>
    <a href="../docs/01-stf-reasoning-templates.html">STF Reasoning Templates</a>
    <a href="../docs/02-stj-repetitivos-patterns.html">STJ Repetitivos Patterns</a>
    <a href="../docs/03-tjsp-plans-vs-sus.html">TJSP: Plans vs SUS</a>
    <a href="../docs/04-conitec-pcdt-vs-courts.html">CONITEC vs Courts</a>
    <a href="../docs/05-interfederative-responsibility.html">Interfederative Responsibility</a>
    </div>
  </div>
  <div class="nav-dropdown">
    <button class="nav-link">Data &#9662;</button>
    <div class="dropdown-menu">
    <a href="../sources/tjsp.html">TJSP</a>
    <a href="../sources/datajud.html">DataJud</a>
    <a href="../sources/stf-stj.html">STF & STJ</a>
    <a href="../sources/trf3.html">TRF3</a>
    <a href="../sources/spending.html">Municipal Spending</a>
    <a href="../sources/legislation.html">Health Legislation</a>
    </div>
  </div>
  <a href="../references/index.html" class="nav-link">References</a>
  <a href="../news/index.html" class="nav-link">News</a>
</nav>
<script>
document.querySelectorAll('.nav-dropdown > .nav-link').forEach(function(btn) {
  btn.addEventListener('click', function(e) {
    e.stopPropagation();
    var dd = btn.parentElement;
    var wasOpen = dd.classList.contains('open');
    document.querySelectorAll('.nav-dropdown.open').forEach(function(d) { d.classList.remove('open'); });
    if (!wasOpen) dd.classList.add('open');
  });
});
document.addEventListener('click', function() {
  document.querySelectorAll('.nav-dropdown.open').forEach(function(d) { d.classList.remove('open'); });
});
</script>

<div class="page-header">
  <h1>Theoretical Framework</h1>
</div>

<main>
<div class="doc-controls">
  <button id="toggle-sections">Expand all</button>
</div>
<div class="md-body">
<h1>Theory — Competing Frameworks and Testable Predictions</h1>
<p>Role: Structured inventory of formal economic theories relevant to the paper. Each framework maps to testable predictions that the judge-IV design can adjudicate.</p>
<p>Status: Populated from formal theory survey. References need verification against primary sources.</p>
<hr />
<h2 id="1-welfare-economics-fairness-vs-welfare">1. Welfare Economics: Fairness vs. Welfare</h2>
<h3 id="core-result">Core result</h3>
<ul>
<li>Kaplow &amp; Shavell (2001, 2002): any non-welfarist social decision rule that gives independent weight to &quot;fairness&quot; or &quot;rights&quot; can be Pareto-dominated by a welfarist rule</li>
<li>Formally: if a legal rule satisfies any notion of fairness that conflicts with welfare maximization, there exists a policy that makes everyone weakly better off and at least one person strictly better off</li>
<li>Result applies to any social welfare function that aggregates individual utilities, not just utilitarianism</li>
<li>Does not say rights are &quot;bad&quot; — says rights must be justified instrumentally (as proxies for welfare) to avoid dominance</li>
</ul>
<h3 id="implication-for-rights-based-health-allocation">Implication for rights-based health allocation</h3>
<ul>
<li>Judicial enforcement of an absolute right to health (&quot;patient entitled to treatment X regardless of cost&quot;) is a non-welfarist rule</li>
<li>If courts ignore opportunity costs, there must exist an alternative allocation that relaxes the right in some states, reallocates resources, and Pareto-improves</li>
<li>Rights-based mandates can only be welfare-improving if they operate through information correction or constraint relaxation, not intrinsic fairness</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Kaplow &amp; Shavell (2001) &quot;Fairness versus Welfare&quot; — Harvard Law Review</li>
<li>Kaplow &amp; Shavell (2002) &quot;Fairness versus Welfare&quot; — Harvard University Press (book-length treatment)</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>Court-mandated spending that ignores opportunity costs reduces aggregate welfare even holding total spending fixed</li>
<li>If courts enforce rights without redistribution (no tax adjustment), some agents must be worse off ex post</li>
<li>Empirical test: compare outcomes where courts enforce procedural rights (process-based) vs. substantive entitlements; only the former should survive a welfare comparison</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Net health effects (population-level) capture whether mandates are welfare-improving or dominated</li>
<li>If negative spillovers on non-litigants outweigh gains to litigants, the Kaplow-Shavell result is operative</li>
<li>Heterogeneity by claim type may reveal which mandates are instrumentally justified vs. purely rights-driven</li>
</ul>
<hr />
<h2 id="2-information-and-allocation-courts-vs-agencies">2. Information and Allocation: Courts vs. Agencies</h2>
<h3 id="a-hayek-1945-dispersed-knowledge">(a) Hayek (1945): Dispersed knowledge</h3>
<ul>
<li>Information about preferences, needs, and local conditions is dispersed and often tacit</li>
<li>Centralized allocation fails when information is local, rapidly changing, and costly to aggregate</li>
<li>Courts responding to individual cases may elicit otherwise unrevealed information (severity, urgency)</li>
<li>But: courts see idiosyncratic information; agencies see systemic trade-offs</li>
<li>Courts solve local information problems but create global inefficiencies</li>
</ul>
<h3 id="b-mechanism-design-myerson-maskin">(b) Mechanism design: Myerson, Maskin</h3>
<ul>
<li>Efficient allocation requires mechanisms that elicit private information truthfully and respect incentive compatibility</li>
<li>Courts operate as ex post mechanisms: information revealed only after harm, no screening ex ante, weak incentive compatibility (agents exaggerate need)</li>
<li>Agencies design ex ante mechanisms (formularies, HTA, budgets)</li>
<li>Courts dominate when ex ante screening is impossible or unreliable</li>
<li>Agencies dominate when mechanisms can be designed to elicit information ex ante</li>
</ul>
<h3 id="c-weitzman-1974-prices-vs-quantities-under-uncertainty">(c) Weitzman (1974): Prices vs. quantities under uncertainty</h3>
<ul>
<li>Health budgets = quantity instruments; court orders = price-like mandates (must fund regardless of cost)</li>
<li>If marginal benefit uncertainty dominates → quantities preferred</li>
<li>If marginal cost uncertainty dominates → prices preferred</li>
<li>Judicial mandates more efficient when marginal benefit uncertainty is large (rare diseases, emergencies)</li>
<li>Inefficient when marginal costs explode (specialty drugs)</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Hayek (1945) &quot;The Use of Knowledge in Society&quot; — AER</li>
<li>Myerson (1979) &quot;Incentive Compatibility and the Bargaining Problem&quot; — Econometrica</li>
<li>Maskin (1999) &quot;Nash Equilibrium and Welfare Optimality&quot; — Review of Economic Studies</li>
<li>Weitzman (1974) &quot;Prices vs. Quantities&quot; — Review of Economic Studies</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>Courts outperform agencies when local/idiosyncratic information matters (heterogeneous conditions, emergencies)</li>
<li>Agencies outperform when standardized screening works (formulary drugs, routine procedures)</li>
<li>Court-mandated spending more efficient for rare/urgent claims, less efficient for common high-cost drugs</li>
<li>Grant rates near 100% regardless of claim type suggest courts are not effectively screening (weak IC)</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Heterogeneity by claim type maps to Hayek/Weitzman: rare diseases vs. common drugs</li>
<li>Judge variation in grant rates tests whether courts function as information-eliciting mechanisms or rubber stamps</li>
<li>Pre/post NATJUS comparison tests whether improving court information shifts toward agency-like efficiency</li>
</ul>
<hr />
<h2 id="3-health-capital-and-diminishing-returns">3. Health Capital and Diminishing Returns</h2>
<h3 id="core-model">Core model</h3>
<ul>
<li>Grossman (1972): health is a capital stock producing healthy time</li>
<li>Individuals invest until marginal cost = marginal benefit</li>
<li>Diminishing returns are fundamental to the model</li>
</ul>
<h3 id="implication-for-court-mandated-spending">Implication for court-mandated spending</h3>
<ul>
<li>Court mandates typically occur at high-cost margins — treatments for conditions already partially managed</li>
<li>Fund treatments late in the health production function where marginal returns are low</li>
<li>Reallocation from preventive/primary care reduces total health capital accumulation</li>
<li>Mandates welfare-improving only when they relax binding credit or insurance constraints at early margins</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Grossman (1972) &quot;On the Concept of Health Capital and the Demand for Health&quot; — JPE</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>Court-mandated treatments lie on the flat portion of the health production function</li>
<li>Marginal returns to judicial spending below inframarginal public health investments (FHP, vaccination, etc.)</li>
<li>Exception: mandates that provide access to cost-effective treatments denied by administrative failure should show high returns</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Judge IV estimates returns to judicially induced spending</li>
<li>Federal transfer IV benchmarks returns to administrative spending</li>
<li>Comparison identifies where on the production function each type of spending operates</li>
<li>Composition analysis: on-formulary (potentially high-return, supply failure) vs. off-formulary (potentially low-return, flat of the curve)</li>
</ul>
<hr />
<h2 id="4-optimal-earmarking">4. Optimal Earmarking</h2>
<h3 id="core-results">Core results</h3>
<ul>
<li>Buchanan (1963): earmarking restricts budget flexibility; equivalent to lump-sum transfers under full fungibility</li>
<li>Hines &amp; Thaler (1995): empirically, grants &quot;stick where they hit&quot; (flypaper effect) — earmarks not fully offset</li>
<li>Brett &amp; Keen (2000): earmarking can be optimal when voters face fiscal illusion</li>
<li>Dhillon &amp; Perroni (2001): earmarking as commitment device when political commitment problems exist</li>
<li>Judicial mandates are de facto earmarks imposed ex post — particularly rigid because they specify items, patients, and procurement channels</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Buchanan (1963) &quot;The Economics of Earmarked Taxes&quot; — JPE</li>
<li>Hines &amp; Thaler (1995) &quot;The Flypaper Effect&quot; — JEP</li>
<li>Brett &amp; Keen (2000) &quot;Political Uncertainty and the Earmarking of Environmental Taxes&quot; — JPublE</li>
<li>Dhillon &amp; Perroni (2001) &quot;Tax Earmarking and Grass-Roots Accountability&quot; — Economics Letters</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>If mandates are fungible: little effect on spending composition (municipalities offset elsewhere)</li>
<li>If flypaper: spending composition shifts toward litigated categories, away from discretionary</li>
<li>Earmarking welfare-improving only if courts target systematically underfunded but high-return health inputs</li>
<li>Earmarking welfare-reducing when it constrains adjustment to shocks (rigidity cost)</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Budget composition analysis: judge-IV effect on spending subcategories</li>
<li>Test fungibility: does judicial spending crowd out other health spending one-for-one, partially, or not at all?</li>
<li>Interaction with fiscal capacity: rigidity costs should be larger in budget-constrained municipalities</li>
<li>ICSAP (avoidable hospitalizations) as outcome captures whether crowd-out hits primary care</li>
</ul>
<hr />
<h2 id="5-regulatory-capture-and-second-best-courts">5. Regulatory Capture and Second-Best Courts</h2>
<h3 id="core-idea">Core idea</h3>
<ul>
<li>Agencies may be captured by industry (Stigler 1971), distorted by career incentives (Laffont &amp; Tirole 1991), or politically constrained (Shleifer &amp; Vishny 1993)</li>
<li>In a second-best world, courts serve as an external enforcement device or constraint on captured regulators</li>
<li>Courts improve welfare when: agency bias is severe, capture is asymmetric, judicial decision-making is harder to capture</li>
<li>Courts reduce welfare when: litigation is itself captured, or judges lack technical capacity</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Stigler (1971) &quot;The Theory of Economic Regulation&quot; — Bell Journal</li>
<li>Laffont &amp; Tirole (1991) &quot;The Politics of Government Decision-Making&quot; — QJE</li>
<li>Shleifer &amp; Vishny (1993) &quot;Corruption&quot; — QJE</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>Judicial mandates welfare-improving when administrative allocation is distorted (political bias, underfunding, capture)</li>
<li>Welfare-reducing when litigation itself is captured (pharma-driven, repeat-player dominated)</li>
<li>Empirical test: interaction between litigation intensity and measures of agency capture/quality</li>
<li>Courts as corrective: effects should be larger where administrative capacity is weakest</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Heterogeneity by municipal administrative capacity, corruption indices, political alignment</li>
<li>If judicial spending has higher returns in poorly governed municipalities → courts as corrective</li>
<li>If returns are low everywhere or only in well-governed municipalities → courts not solving a capture problem</li>
</ul>
<hr />
<h2 id="6-property-rules-vs-liability-rules">6. Property Rules vs. Liability Rules</h2>
<h3 id="core-framework">Core framework</h3>
<ul>
<li>Calabresi &amp; Melamed (1972): entitlements can be protected by property rules (injunctions) or liability rules (damages/compensation)</li>
<li>Court injunctions in health = property rules (&quot;treatment must be provided&quot;)</li>
<li>Administrative discretion with compensation = liability rules (coverage decisions + appeals)</li>
</ul>
<h3 id="key-result">Key result</h3>
<ul>
<li>Property rules efficient when transaction costs are low and entitlement valuation is hard</li>
<li>Liability rules dominate when bargaining is costly and damages can be priced</li>
<li>Health context: valuation of health loss is genuinely difficult, but bargaining over budget allocation is also costly</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Calabresi &amp; Melamed (1972) &quot;Property Rules, Liability Rules, and Inalienability&quot; — Harvard Law Review</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>Judicial mandates (property-rule enforcement) efficient only when valuation of health loss is infeasible and bargaining is impossible</li>
<li>Otherwise, liability-style compensation (administrative coverage with appeal rights) dominates</li>
<li>Prediction: injunctive orders for easily valued treatments (standard drugs with known prices) are inefficient; for hard-to-value conditions (rare diseases, emergencies) they may be justified</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Heterogeneity by claim type: standard vs. non-standard treatments</li>
<li>Whether property-rule enforcement (must provide) leads to worse outcomes than administrative processes with appeal mechanisms</li>
</ul>
<hr />
<h2 id="7-procurement-and-moral-hazard">7. Procurement and Moral Hazard</h2>
<h3 id="core-model">Core model</h3>
<ul>
<li>Laffont &amp; Tirole (1993): efficient procurement requires competition, commitment, and price discipline</li>
<li>Court-ordered procurement bypasses auctions, eliminates commitment, weakens incentives for cost revelation</li>
<li>Suppliers face reduced incentive to price affordably or negotiate discounts when courts enforce coverage</li>
<li>Creates supplier moral hazard: pharma companies may encourage litigation as market access strategy</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Laffont &amp; Tirole (1993) &quot;A Theory of Incentives in Procurement and Regulation&quot; — MIT Press</li>
<li>Genicolo-Martins &amp; Furquim de Azevedo (2024) — procurement cost premium (30-44% markup in urgent judicial tenders)</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>Prices paid under court mandates exceed benchmark procurement prices</li>
<li>Suppliers invest less in cost reduction when judicial route available</li>
<li>Entry incentives distort toward litigation-friendly products (high-cost, patented, non-formulary)</li>
<li>Litigation concentrates on drugs not cost-effective enough to pass HTA (CONITEC) but profitable enough to litigate</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Composition of judicially mandated items (on-list vs. off-list, generic vs. branded)</li>
<li>Price comparisons: judicial vs. administrative procurement (Genicolo-Martins data)</li>
<li>Whether mandated treatments have evidence-based efficacy</li>
</ul>
<hr />
<h2 id="8-litigation-selection-and-distribution">8. Litigation, Selection, and Distribution</h2>
<h3 id="a-shavell-1982-1997-private-vs-social-incentives-to-sue">(a) Shavell (1982, 1997): Private vs. social incentives to sue</h3>
<ul>
<li>Private incentive to sue ≠ social incentive</li>
<li>Over-litigation when private gains exceed social benefits</li>
<li>Under-litigation for diffuse harms</li>
<li>In health: individuals capture full benefit of mandated treatment but impose diffuse costs on the system</li>
</ul>
<h3 id="b-bebchuk-1984-litigation-under-asymmetric-information">(b) Bebchuk (1984): Litigation under asymmetric information</h3>
<ul>
<li>Stronger parties settle advantageously</li>
<li>Weaker parties drop claims</li>
<li>Predicts that better-resourced plaintiffs (or those with pharma/legal support) are more likely to litigate and win</li>
</ul>
<h3 id="c-priest-amp-klein-1984-selection-of-disputes">(c) Priest &amp; Klein (1984): Selection of disputes</h3>
<ul>
<li>Litigated cases are selected disputes, not representative</li>
<li>Close cases go to trial; clear-cut cases settle or are never filed</li>
<li>Implication: observed litigation may not represent the full distribution of unmet health needs</li>
</ul>
<h3 id="d-galanter-1974-repeat-players-vs-one-shotters">(d) Galanter (1974): Repeat players vs. one-shotters</h3>
<ul>
<li>Repeat players have lower unit costs, learning advantages, strategic behavior</li>
<li>One-shot litigants (typical patients) are disadvantaged</li>
<li>Exception: public defenders and patient associations can function as repeat players on behalf of the poor</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Shavell (1982) &quot;The Social versus the Private Incentive to Bring Suit&quot; — JLS</li>
<li>Shavell (1997) &quot;The Fundamental Divergence between the Private and the Social Motive to Use the Legal System&quot; — JLS</li>
<li>Bebchuk (1984) &quot;Litigation and Settlement under Imperfect Information&quot; — RAND Journal</li>
<li>Priest &amp; Klein (1984) &quot;The Selection of Disputes for Litigation&quot; — JLS</li>
<li>Galanter (1974) &quot;Why the 'Haves' Come Out Ahead&quot; — Law &amp; Society Review</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>Litigation skews toward higher-income, better-informed, repeat or supported plaintiffs</li>
<li>Progressive litigation requires: low filing costs, legal aid, collective/class mechanisms, standardized claims</li>
<li>Otherwise, redistribution is regressive in equilibrium</li>
<li>Public defenders as repeat players: where Defensoria Pública is strong, litigation composition should be more progressive</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Heterogeneity by municipality income/HDI and Defensoria presence</li>
<li>Plaintiff characteristics (where available): income, representation type</li>
<li>Whether judicial spending narrows or widens health outcome gaps across municipalities</li>
<li>Test Galanter prediction: effects of litigation may differ by legal representation type</li>
</ul>
<hr />
<h2 id="9-fiscal-federalism-and-unfunded-mandates">9. Fiscal Federalism and Unfunded Mandates</h2>
<h3 id="core-idea">Core idea</h3>
<ul>
<li>Oates (1972, 1999): fiscal decentralization assigns spending to the level of government with best information, but assumes appropriate budget constraints and matching of responsibilities to revenues</li>
<li>Judicial mandates violate this assignment: courts interpreting federal constitutional rights impose costs on municipal budgets without corresponding revenue transfers</li>
<li>Solidary liability (Art. 23) means any level of government can be ordered to pay; in practice municipalities bear costs that SUS rules assign to states or federal government</li>
<li>Creates a vertical fiscal externality: court orders at the state level generate spending obligations at the municipal level</li>
</ul>
<h3 id="soft-budget-constraint-connection">Soft budget constraint connection</h3>
<ul>
<li>Kornai (1986), Kornai, Maskin &amp; Roland (2003): when agents expect bailouts, budget discipline erodes</li>
<li>In the judicial context, the reverse problem: courts impose <em>hard</em> mandates (immediate compliance, bank account seizure) on municipal budgets designed with certain flexibility</li>
<li>But also a forward-looking SBC: if municipalities expect courts to mandate spending, they may under-invest in administrative capacity for drug delivery (why build procurement systems if courts will order emergency purchases anyway?)</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Oates (1972) &quot;Fiscal Federalism&quot; — Harcourt Brace</li>
<li>Oates (1999) &quot;An Essay on Fiscal Federalism&quot; — JEL, 37(3)</li>
<li>Kornai (1986) &quot;The Soft Budget Constraint&quot; — Kyklos, 39(1)</li>
<li>Kornai, Maskin &amp; Roland (2003) &quot;Understanding the Soft Budget Constraint&quot; — JEL, 41(4)</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>Judicial spending has larger negative effects in municipalities that bear costs misassigned from higher levels of government (vertical mismatch)</li>
<li>Municipalities with less fiscal capacity (lower own-source revenue) are more vulnerable to mandate shocks</li>
<li>If SBC logic operates: municipalities with more litigation history may invest less in administrative pharmaceutical delivery</li>
<li>Post-Tema 793 (2019, rationalizing cost assignment) and post-2024 federal reimbursement mechanism: effects should attenuate if vertical mismatch is resolved</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Paper documents that 55% of SP municipal judicial pharma spending was for state/federal-responsibility drugs (Wang 2014)</li>
<li>Heterogeneity by fiscal capacity and revenue composition</li>
<li>Pre/post Tema 793 and 2024 reimbursement reforms as natural breaks</li>
<li>Whether crowd-out is driven by mandates within municipal responsibility vs. misassigned mandates</li>
</ul>
<hr />
<h2 id="10-supplier-induced-demand">10. Supplier-Induced Demand</h2>
<h3 id="core-idea">Core idea</h3>
<ul>
<li>Arrow (1963): health care markets fail because of information asymmetry between providers and patients; providers can exploit this to shift demand</li>
<li>Evans (1974), McGuire (2000): physician-induced demand (PID) — doctors can recommend treatments beyond what a fully informed patient would choose, because patients cannot evaluate clinical necessity independently</li>
<li>In the judicial context: the doctor-lawyer-pharma referral chain creates a demand inducement channel via the legal system</li>
<li>Physicians prescribe specific (often branded, non-formulary) drugs → refer patients to specialized law firms → courts order provision at public expense</li>
<li>This is PID mediated through litigation rather than direct provision</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Arrow (1963) &quot;Uncertainty and the Welfare Economics of Medical Care&quot; — AER, 53(5)</li>
<li>Evans (1974) &quot;Supplier-Induced Demand: Some Empirical Evidence and Implications&quot; — in Perlman (ed.), The Economics of Health and Medical Care</li>
<li>McGuire (2000) &quot;Physician Agency&quot; — Handbook of Health Economics, Vol. 1, Ch. 9</li>
<li>Dranove (1988) &quot;Demand Inducement and the Physician/Patient Relationship&quot; — Economic Inquiry, 26(2)</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>Supply-driven litigation concentrates on high-margin, non-formulary, patented drugs</li>
<li>Lawyer concentration predicts litigation volume independent of health need (19 lawyers filed 63% of SP cases)</li>
<li>Physician prescribing patterns cluster around specific drugs associated with pharma marketing</li>
<li>If SID dominates: health returns to supply-driven cases should be lower than demand-driven cases (patients with genuine unmet needs)</li>
<li>Reducing supply-side incentives (e.g., pharma enforcement operations) should reduce litigation without worsening health outcomes</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Paper's supply-side section (Sec 7.4) documents lawyer concentration and pharma networks</li>
<li>Split by high-volume vs. low-volume lawyers tests whether supply-driven margin has different health returns</li>
<li>Composition of mandated items (branded vs. generic, on-list vs. off-list) as proxy for SID</li>
<li>Operação Garra Rufa / eculizumab as case studies of extreme SID</li>
</ul>
<hr />
<h2 id="11-dynamic-commitment-and-ratchet-effects">11. Dynamic Commitment and Ratchet Effects</h2>
<h3 id="core-idea">Core idea</h3>
<ul>
<li>Freixas, Guesnerie &amp; Tirole (1985): under incomplete information, past performance constrains future flexibility (ratchet effect)</li>
<li>Applied to judicial mandates: once a court orders a chronic medication, the commitment is indefinite — mandates accumulate rather than expire</li>
<li>Each successful lawsuit creates a recurring budget obligation; the stock of active mandates grows over time even if new filing rates are constant</li>
<li>Budget rigidification: the share of the health budget pre-committed to judicial mandates ratchets upward, shrinking the discretionary margin</li>
</ul>
<h3 id="precedent-ratchet">Precedent ratchet</h3>
<ul>
<li>Judicial precedent creates a one-way ratchet: once a treatment is established as judicially obtainable, denial becomes harder</li>
<li>Lawyers cite prior grants; judges face reputational/legal costs of diverging from established patterns</li>
<li>Combined with supply-side inducement, this creates a self-reinforcing cycle: precedent → more cases → more precedent</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Freixas, Guesnerie &amp; Tirole (1985) &quot;Planning under Incomplete Information and the Ratchet Effect&quot; — Review of Economic Studies, 52(2)</li>
<li>Kornai, Maskin &amp; Roland (2003) &quot;Understanding the Soft Budget Constraint&quot; — JEL, 41(4)</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>Cumulative stock of active mandates (not just flow) predicts budget pressure and health outcomes</li>
<li>Municipalities with longer litigation histories have less fiscal flexibility and worse health indicators, controlling for current spending</li>
<li>Dynamic event-study: effects worsen over time as mandates accumulate (not just contemporaneous shock)</li>
<li>New mandate effects larger when existing stock of mandates is high (nonlinear/convex costs of rigidity)</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Paper's event-study specification (Sec 5.3) can capture dynamic accumulation</li>
<li>Stock vs. flow distinction in the first stage: current-year judge assignments vs. accumulated mandates</li>
<li>Whether crowd-out effects are larger in municipalities with longer litigation exposure</li>
</ul>
<hr />
<h2 id="12-behavioral-judicial-decision-making">12. Behavioral Judicial Decision-Making</h2>
<h3 id="core-idea">Core idea</h3>
<ul>
<li>Judges are subject to systematic cognitive biases that affect the quality of health resource allocation via courts</li>
<li>Standard economic models assume judges optimize (or at least act as rational agents); behavioral evidence suggests systematic departures</li>
</ul>
<h3 id="a-identifiable-victim-effect">(a) Identifiable victim effect</h3>
<ul>
<li>Schelling (1968): people allocate more resources to save identified individuals than statistical lives</li>
<li>Judges see the specific patient in the courtroom; the statistical lives lost from crowd-out of primary care are invisible</li>
<li>Predicts systematic over-granting: the identifiable patient always &quot;wins&quot; against the abstract population</li>
</ul>
<h3 id="b-omission-bias-and-action-bias">(b) Omission bias and action bias</h3>
<ul>
<li>Denying a treatment feels like causing harm (action); granting feels like helping (but the crowd-out harm is omission)</li>
<li>Judges face asymmetric reputational risk: denial may lead to patient death attributed to the judge; granting spreads costs diffusely across the budget</li>
<li>Consistent with 93% grant rates regardless of clinical merit</li>
</ul>
<h3 id="c-anchoring-on-plaintiff-evidence">(c) Anchoring on plaintiff evidence</h3>
<ul>
<li>Guthrie, Rachlinski &amp; Wistrich (2001): judges anchor on initial information presented</li>
<li>In health cases, plaintiff presents medical prescription and clinical urgency; defendant (municipality) presents budget constraints and formulary rules</li>
<li>Anchoring on clinical framing shifts decisions toward granting</li>
</ul>
<h3 id="d-sequential-decision-patterns">(d) Sequential decision patterns</h3>
<ul>
<li>Chen, Moskowitz &amp; Shue (2016): decision-makers exhibit gambler's fallacy in sequential decisions — after a streak of similar decisions, they switch</li>
<li>May generate random-looking variation in grant rates that is actually driven by sequence position rather than case merits</li>
</ul>
<h3 id="key-references">Key references</h3>
<ul>
<li>Schelling (1968) &quot;The Life You Save May Be Your Own&quot; — in Chase (ed.), Problems in Public Expenditure Analysis</li>
<li>Guthrie, Rachlinski &amp; Wistrich (2001) &quot;Inside the Judicial Mind&quot; — Cornell Law Review, 86</li>
<li>Jolls, Sunstein &amp; Thaler (1998) &quot;A Behavioral Approach to Law and Economics&quot; — Stanford Law Review, 50</li>
<li>Chen, Moskowitz &amp; Shue (2016) &quot;Decision Making Under the Gambler's Fallacy&quot; — QJE, 131(3)</li>
</ul>
<h3 id="testable-predictions">Testable predictions</h3>
<ul>
<li>Grant rates near 100% despite heterogeneous clinical merit → identifiable victim effect + omission bias dominating</li>
<li>Judge variation driven by cognitive style (some judges more susceptible to anchoring) rather than policy preferences</li>
<li>Sequential patterns in grant/deny decisions within judge (Chen et al.)</li>
<li>NATJUS technical notes reduce anchoring on plaintiff evidence: post-NATJUS grant rates should be more sensitive to clinical merit</li>
<li>Judges who consult NATJUS should show more variation in grant rates (discriminating between cases) vs. rubber-stamping judges</li>
</ul>
<h3 id="connection-to-our-design">Connection to our design</h3>
<ul>
<li>Judge heterogeneity in grant rates may reflect cognitive differences, not just policy preferences</li>
<li>Whether NATJUS consultation predicts better allocation (higher health returns per mandate)</li>
<li>Can test Chen et al. sequential patterns using case-level data within judges</li>
<li>If behavioral biases dominate: reforms improving judicial information (NATJUS) should matter more than reforms tightening legal standards (Tema 106)</li>
</ul>
<hr />
<h2 id="overarching-framing-for-the-paper">Overarching Framing for the Paper</h2>
<h3 id="theoretical-benchmark">Theoretical benchmark</h3>
<ul>
<li>Judicial mandates for health spending are never first-best in standard economic theory</li>
<li>They can be second-best corrections to capture, information failure, or political neglect</li>
<li>They are welfare-reducing when they function as absolute rights, rigid earmarks, or procurement bypasses</li>
</ul>
<h3 id="central-empirical-question-theory-derived">Central empirical question (theory-derived)</h3>
<blockquote>
<p>When do courts operate as corrective mechanisms, and when do they create predictable distortions?</p>
</blockquote>
<h3 id="two-polar-views">Two polar views</h3>
<p><strong>Optimistic (courts as corrective):</strong></p>
<ul>
<li>Administrative allocation fails due to capture, underfunding, or political neglect (Stigler, Laffont-Tirole)</li>
<li>Courts correct under-provision by eliciting local information (Hayek) and enforcing entitlements</li>
<li>Earmarking corrects political underprovision (Dhillon &amp; Perroni 2001, Brett &amp; Keen 2000)</li>
<li>Courts force higher governments to meet their fiscal obligations (correcting vertical mismatch, Oates)</li>
<li>Predicts: positive health returns, progressive incidence, effects concentrated where admin capacity is weakest</li>
</ul>
<p><strong>Pessimistic (courts as distortionary):</strong></p>
<ul>
<li>Courts lack information for efficient allocation (mechanism design); mandates at flat of production function (Grossman)</li>
<li>Rights-based rules Pareto-dominated (Kaplow-Shavell)</li>
<li>Litigation captured by repeat players and pharma (Galanter, Laffont-Tirole procurement)</li>
<li>Supplier-induced demand inflates litigation beyond clinical need (Arrow, McGuire, Evans)</li>
<li>Rigid earmarks reduce allocative flexibility; crowd out high-return spending</li>
<li>Ratchet effects: mandates accumulate, progressively rigidifying budgets (Freixas-Guesnerie-Tirole)</li>
<li>Vertical fiscal externalities: costs fall on municipalities that lack capacity to absorb them (Oates, Kornai)</li>
<li>Behavioral biases (identifiable victim, omission bias) produce systematic over-granting (Schelling, Guthrie et al.)</li>
<li>Predicts: low/negative health returns, regressive incidence, crowd-out of PHC, escalating fiscal burden</li>
</ul>
<h3 id="our-contribution">Our contribution</h3>
<ul>
<li>Causal estimates that distinguish between these views</li>
<li>Judge-IV design identifies whether judicially induced spending improves or worsens population health</li>
<li>Heterogeneity analysis maps to specific theoretical mechanisms (claim type, municipal capacity, plaintiff characteristics, legal representation, pre/post reform)</li>
<li>Comparison with administrative spending returns (federal transfer IV) directly tests relative allocative efficiency</li>
<li>Supply-side analysis (lawyer concentration splits) tests demand inducement channel</li>
<li>Dynamic event-study captures ratchet/accumulation effects beyond contemporaneous shocks</li>
</ul>

</div>
</main>

<footer>
  Generated by <code>bash build.sh site</code>
</footer>

<script>
document.addEventListener('DOMContentLoaded', () => {
  const body = document.querySelector('.md-body');
  if (!body) return;

  function foldHeadings(container, tag) {
    const level = tag.replace('H', '');
    const headings = Array.from(container.querySelectorAll(':scope > ' + tag.toLowerCase()));
    headings.forEach(h => {
      const details = document.createElement('details');
      details.className = 'level-' + level;
      if (h.id) details.id = h.id;
      const summary = document.createElement('summary');
      summary.innerHTML = h.innerHTML;
      details.appendChild(summary);
      let sibling = h.nextElementSibling;
      const collected = [];
      while (sibling && sibling.tagName !== tag) {
        collected.push(sibling);
        sibling = sibling.nextElementSibling;
      }
      collected.forEach(el => details.appendChild(el));
      h.replaceWith(details);
    });
    return headings.length;
  }

  // Fold h2 sections, then h3 sections within each h2
  const count = foldHeadings(body, 'H2');
  if (count === 0) {
    document.querySelector('.doc-controls').style.display = 'none';
    return;
  }
  body.querySelectorAll('details.level-2').forEach(d => foldHeadings(d, 'H3'));

  // Toggle button
  const btn = document.getElementById('toggle-sections');
  if (!btn) return;
  btn.addEventListener('click', () => {
    const allDetails = body.querySelectorAll('details');
    const expanding = btn.textContent === 'Expand all';
    allDetails.forEach(d => d.open = expanding);
    btn.textContent = expanding ? 'Collapse all' : 'Expand all';
  });

  // Auto-open details when navigating to an anchor
  function openAnchorTarget() {
    if (!location.hash) return;
    const target = document.querySelector(location.hash);
    if (!target) return;
    let el = target;
    while (el) {
      if (el.tagName === 'DETAILS') el.open = true;
      el = el.parentElement;
    }
    target.scrollIntoView();
  }
  openAnchorTarget();
  window.addEventListener('hashchange', openAnchorTarget);
});
</script>

</body>
</html>
